TFM
REGN icon

TFC Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

TFC Financial Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5K Sell
89
-15
-14% -$10.2K 0.01% 281
2026
Q1 		$80.4K Hold
104
– – 0.01% 224
2025
Q4 		$80.3K Buy
104
+1
+1% +$679 0.01% 233
2025
Q3 		$57.9K Buy
103
+1
+1% +$565 0.01% 257
2025
Q2 		$53.5K Sell
102
-100
-50% -$55.8K 0.01% 252
2025
Q1 		$128K Sell
202
-70
-26% -$48.1K 0.02% 162
2024
Q4 		$194K Buy
272
+8
+3% +$6.71K 0.03% 128
2024
Q3 		$278K Hold
264
– – 0.04% 111
2024
Q2 		$277K Buy
264
+1
+0.4% +$969 0.05% 97
2024
Q1 		$253K Hold
263
– – 0.05% 99
2023
Q4 		$231K Hold
263
– – 0.05% 103
2023
Q3 		$216K Hold
263
– – 0.05% 98
2023
Q2 		$189K Buy
263
+1
+0.4% +$771 0.05% 114
2023
Q1 		$215K Buy
262
+1
+0.4% +$754 0.06% 99
2022
Q4 		$188K Hold
261
– – 0.05% 97
2022
Q3 		$180K Buy
261
+160
+158% +$101K 0.06% 95
2022
Q2 		$60K Buy
101
+1
+1% +$650 0.02% 190
2022
Q1 		$70K Hold
100
– – 0.02% 182
2021
Q4 		$63K Buy
100
+99
+9,900% +$60.9K 0.02% 201
2021
Q3 		$1K Hold
1
– – ﹤0.01% 537
2021
Q2 		$1K Hold
1
– – ﹤0.01% 541
2021
Q1 		$0 Hold
1
– – ﹤0.01% 590
2020
Q4 		$0 Hold
1
– – ﹤0.01% 585
2020
Q3 		$1K Buy
+1
New +$606 ﹤0.01% 486

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TFC Financial Management's REGN Position: Q2 2026 in Review

TFC Financial Management reduced its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, selling an estimated $10.2K and leaving 89 shares worth $55.5K. The position accounts for 0.01% of the portfolio, ranked #281.

TFC Financial Management first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $278K in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • TFC Financial Management held 89 shares of Regeneron Pharmaceuticals worth $55.5K as of Q2 2026.
  • TFC Financial Management sold 15 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Regeneron Pharmaceuticals made up 0.01% of TFC Financial Management's portfolio in Q2 2026, its #281 holding.
  • TFC Financial Management first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • TFC Financial Management's Regeneron Pharmaceuticals position peaked at $278K in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.